Exploring the relationship between anorexia and therapeutic efficacy in advanced lung cancer treatment: a retrospective study.
Kosei DoshitaTateaki NaitoSuguru MatsudaMeiko MoritaMotoki SekikawaKeita MiuraHiroaki KodamaMichitoshi YabeNoboru MorikawaYuko IidaNobuaki MamesayaHaruki KobayashiRyo KoKazushige WakudaAkira OnoHaruyasu MurakamiHirotsugu KenmotsuToshiaki TakahashiPublished in: Thoracic cancer (2024)
Chemotherapy-induced anorexia was associated with significant weight loss and reduced treatment efficacy in patients with stage IV non-small-cell lung cancer. These results highlight the importance of implementing robust supportive care for chemotherapy-induced anorexia to mitigate weight loss and uphold treatment effectiveness during platinum-based chemotherapy combined with immune checkpoint inhibitors.
Keyphrases
- chemotherapy induced
- weight loss
- bariatric surgery
- healthcare
- randomized controlled trial
- roux en y gastric bypass
- systematic review
- palliative care
- type diabetes
- quality improvement
- metabolic syndrome
- gastric bypass
- squamous cell carcinoma
- radiation therapy
- body mass index
- combination therapy
- skeletal muscle
- chronic pain
- adipose tissue